Criterium

Criterium is a long-established, privately-held CRO that has carved out a specialized niche in oncology clinical research through its innovative Oncology Consortia model. The company combines hands-on operational expertise with technology solutions like interactive voice/web response (IVR/IWR) and ePRO to manage complex trials efficiently. Its core strategy involves forming disease-specific consortia with top-tier universities and cancer centers, enabling rapid patient recruitment and high-quality data generation for pharmaceutical and biotech sponsors. While primarily a service provider, its deep integration into therapeutic development gives it significant insight into the oncology pipeline landscape.

Integrated clinical trial technology suite including Interactive Voice/Web Response (IVR/IWR), electronic Patient-Reported Outcomes (ePRO), and remote monitoring capabilities, designed to support a Centralized Network Model for efficient trial management.

Criterium competes in the fragmented CRO market, facing giants like IQVIA and ICON, as well as other mid-sized and niche oncology-focused CROs. Its primary competitive differentiation is its hands-on, consortium-based operational model and deep therapeutic expertise in oncology.